Letter to the Editor: Cannabidiol is psychoactive von Gauvin, David V

Volltext

Preclinical assessment of the abuse potential of the orexin receptor antagonist, suvorexant von Born, Stephanie, Gauvin, David V., Mukherjee, Suman, Briscoe, Richard

Volltext

NOEL and NOAEL: A retrospective analysis of mention in a sample of recently conducted safety pharmacology studies von Baird, Theodore J., Caruso, Michael J., Gauvin, David V., Dalton, Jill A.

Volltext

MP54: Management algorithm for the treatment of intoxications with calcium channel blockers: a simulation trial (MATRICS) von Gauvin, V., Raymond-Dufresne, É., St-Onge, M.

Volltext

The standardized functional observational battery: Its intrinsic value remains in the instrument of measure: The rat von Gauvin, David V., Yoder, Joshua D., Holdsworth, David L., Harter, Marci L., May, Jonelle R., Cotey, Noelle, Dalton, Jill A., Baird, Theodore J.

Volltext

A Commentary on Fasting of Nonclinical Research Animals von Gauvin, David V., McComb, Margaret, Farero, Ryan

Volltext

Long-Term Results of the NAIS Procedure for Aortic-Graft Infections and Mycotic Aneurysms: A Single-Center Experience von Gauvin, V, Bernatchez, J, Rheaume, P

Volltext

Establishing performance characteristics for positive control article selection in drug self-administration studies von Gauvin, David V., Zimmermann, Zachary J., Kallman, Mary Jeanne

Volltext

MP55: Reducing barriers to successful cardiac resuscitation: intervention in elementary schools von Blanchard, P., Gauvin, V., Marie-Pier, L., Péloquin, F., Bertrand, I., Mercier, E.

Volltext

Repeated “Day 1” FOB testing in ICH S7A safety assessment protocols: The influence of within- and between-session learning von Gauvin, David V., Zimmermann, Zachary J., Dalton, Jill A., Baird, Theodore J.

Volltext

The gold-standard in preclinical abuse liability testing: It's all relative von Gauvin, David V., Zimmermann, Zachary J., Baird, Theodore J.

Volltext

Study design criteria for regulatory-based drug control action: Drug discrimination von Gauvin, David V., Zimmermann, Zachary J.

Volltext

De-risking in Tier I CNS safety assessments is the primary function of study design and technical training of laboratory staff observers von Gauvin, David V., Zimmermann, Zachary J., Dalton, Jill A.

Volltext

The failure to detect drug-induced sensory loss in standard preclinical studies von Gauvin, David V., Abernathy, Matthew M., Tapp, Rachel L., Yoder, Joshua D., Dalton, Jill A., Baird, Theodore J.

Volltext

A reply to Henningfield, Fant & Wang (2018): regulatory action to control kratom is long overdue von Gauvin, David V., Zimmermann, Zachary J.

Volltext

A functional observational battery in non-human primates for regulatory-required neurobehavioral assessments von Gauvin, David V., Baird, Theodore J.

Volltext

Method of data interpretation for the determination of abuse liability in rodent self-administration studies under the FDA guidance document von Gauvin, David V., Zimmermann, Zachary J., Baird, Theodore J.

Volltext

FOB vs modified Irwin: What are we doing? von Gauvin, David V., Zimmermann, Zachary J.

Volltext

Nonclinical evaluation of abuse liability of the dual orexin receptor antagonist lemborexant von Asakura, Shoji, Shiotani, Motohiro, Gauvin, David V., Fujiwara, Atsushi, Ueno, Takashi, Bower, Nancy, Beuckmann, Carsten T., Moline, Margaret

Volltext

Discriminative stimulus effects of cocaine-levamisole combinations in Sprague-Dawley rats von Zimmermann, Zachary J, Gauvin, David V, Poling, Alan

Volltext